Castleview Partners, LLC - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 84 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Castleview Partners, LLC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$368
-41.6%
5000.0%0.00%
-100.0%
Q2 2023$630
+74.0%
5000.0%0.00%
Q1 2023$362
+37.1%
5000.0%0.00%
Q4 2022$2645000.0%0.00%
Q3 2022$0
-100.0%
500
+502.4%
0.00%
Q2 2022$110,00083
-83.4%
0.00%
Q1 2022$0
-100.0%
500
-37.5%
0.00%
-100.0%
Q4 2021$500,000
+16566.7%
800
+60.0%
0.00%
+300.0%
Q2 2021$3,0005000.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 347,392$2560.02%
XTX Topco Ltd 167,427$123,3100.02%
Laurion Capital Management LP 2,225,800$1,639,3020.01%
Virtu Financial LLC 80,728$590.01%
Renaissance Technologies 1,242,370$9150.00%
LVM CAPITAL MANAGEMENT LTD/MI 21,000$150.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,8250.00%
Connor, Clark & Lunn Investment Management Ltd. 133,591$98,3900.00%
Caption Management, LLC 75,000$55,2380.00%
J. L. Bainbridge & Co., Inc. 11,121$8,1910.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders